Severe Fever with Thrombocytopenia Syndrome
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Severe fever with thrombocytopenia syndrome (SFTS) is a newly emerging infectious disease, caused by a novel species of Phlebovirus of Bunyaviridae family, in China, South Korea, and Japan. SFTS is primarily known as a tick-borne disease, and human-to-human transmission is also possible in contact with infectious blood. Common clinical manifestations include fever, thrombocytopenia, and leukopenia as initial symptoms, and multiple organ dysfunction and failure manifest with disease progression. Whereas disease mortality is reported to be 12% to 30% in China, a recent report of cumulative SFTS cases indicated 47% in Korea. Risk factors associated with SFTS were age, presence of neurologic disturbance, serum enzyme levels, and elevated concentrations of certain cytokines. Diagnosis of SFTS is based on viral isolation, viral identification by polymerase chain reaction, and serologic identification of specific immunoglobulin G. Therapeutic guideline has not been formulated, but conservative management is the mainstream of treatment to prevent disease progression and fatal complications.
Abstract
Severe fever with thrombocytopenia syndrome (SFTS) is a newly emerging infectious disease, caused by a novel species of Phlebovirus of Bunyaviridae family, in China, South Korea, and Japan. SFTS is primarily known as a tick-borne disease, and human-to-human transmission is also possible in contact with infectious blood. Common clinical manifestations include fever, thrombocytopenia, and leukopenia as initial symptoms, and multiple organ dysfunction and failure manifest with disease progression. Whereas disease mortality is reported to be 12% to 30% in China, a recent report of cumulative SFTS cases indicated 47% in Korea. Risk factors associated with SFTS were age, presence of neurologic disturbance, serum enzyme levels, and elevated concentrations of certain cytokines. Diagnosis of SFTS is based on viral isolation, viral identification by polymerase chain reaction, and serologic identification of specific immunoglobulin G. Therapeutic guideline has not been formulated, but conservative management is the mainstream of treatment to prevent disease progression and fatal complications.
참고문헌 (23)
- Gai ZT, "Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients", J Infect Dis, 206, pp.1095~1102 (2012)
- Liu S, "Systematic review of severe fever with thrombocytopenia syndrome:virology, epidemiology, and clinical characteristics", Rev Med Virol, 24, pp.90~102 (2014)
- Takahashi T, "The first identification and retrospective study of severe Fever with thrombocytopenia syndrome in Japan", J Infect Dis, 209, pp.816~827 (2014)
- Zhang YZ, "Hemorrhagic fever caused by a novel Bunyavirus in China: pathogenesis and correlates of fatal outcome", Clin Infect Dis, 54, pp.527~533 (2012)
- Yu XJ, "Fever with thrombocytopenia associated with a novel bunyavirus in China", N Engl J Med, 364, pp.1523~1532 (2011)
- Ding F, "Epidemiologic features of severe fever with thrombocytopenia syndrome in China, 2011-2012", Clin Infect Dis, 56, pp.1682~1683 (2013)
- Denic S, "Acute Thrombocytopenia, Leucopenia, and Multiorgan Dysfunction: The First Case of SFTS Bunyavirus outside China?", Case Rep Infect Dis, 2011, pp.204056~ (2011)
- Kim KH, "Severe fever with thrombocytopenia syndrome, South Korea, 2012", Emerg Infect Dis, 19, pp.1892~1894 (2013)
- 장미수, "Severe Fever with Thrombocytopenia Syndrome: Tick-Mediated Viral Disease", Journal of Korean Medical Science, 28(6), pp.795~796 (2013), 대한의학회
- "Korea Center for Disease Control and Prevention" (2014)[URL]
- Zhang YZ, "The ecology, genetic diversity, and phylogeny of Huaiyangshan virus in China", J Virol, 86, pp.2864~2868 (2012)
- Zhao L, "Severe fever with thrombocytopenia syndrome virus, Shandong Province, China", Emerg Infect Dis, 18, pp.963~965 (2012)
- Tang X, "Human-to-human transmission of severe fever with thrombocytopenia syndrome bunyavirus through contact with infectious blood", J Infect Dis, 207, pp.736~739 (2013)
- Bao CJ, "A family cluster of infections by a newly recognized bunyavirus in eastern China, 2007: further evidence of person-to-person transmission", Clin Infect Dis, 53, pp.1208~1214 (2011)
- Gai Z, "Person-to-person transmission of severe fever with thrombocytopenia syndrome bunyavirus through blood contact", Clin Infect Dis, 54, pp.249~252 (2012)
- 허상택, "제주지역에서 발생한 중증열성혈소판감소증후군 4예", 대한피부과학회지, 52(3), pp.173~177 (2014), 대한피부과학회
- Li J, "Concurrent measurement of dynamic changes in viral load, serum enzymes, T cell subsets, and cytokines in patients with severe Fever with thrombocytopenia syndrome", PLoS One, 9, pp.e91679~ (2014)
- Deng B, "Cytokine and chemokine levels in patients with severe fever with thrombocytopenia syndrome virus", PLoS One, 7, pp.e41365~ (2012)
- Deng B, "Clinical features and factors associated with severity and fatality among patients with severe fever with thrombocytopenia syndrome Bunyavirus infection in Northeast China", PLoS One, 8, pp.e80802~ (2013)
- Liu W, "Case-fatality ratio and effectiveness of ribavirin therapy among hospitalized patients in china who had severe fever with thrombocytopenia syndrome", Clin Infect Dis, 57, pp.1292~1299 (2013)
- Oh WS, "Plasma exchange and ribavirin for rapidly progressive severe fever with thrombocytopenia syndrome", Int J Infect Dis, 18, pp.84~86 (2014)
- Erduran E, "The treatment of crimean-congo hemorrhagic fever with high-dose methylprednisolone, intravenous immunoglobulin, and fresh frozen plasma", J Pediatr Hematol Oncol, 35, pp.e19~e24 (2013)
- Pastula DM, "Notes from the field: heartland virus disease - United States, 2012-2013", MMWR Morb Mortal Wkly Rep, 63, pp.270~271 (2014)